Drug usage review and inventory analysis in promoting rational parenteral cephalosporin therapy.
Drug usage review and inventory analysis data on the cephalosporin antibotics were presented by the pharmacy to a hospital pharmacy and therapeutics committee in an effort to promote rational use of these drugs and decrease drug costs. The committee recommended that cefazolin be the parenteral cephalosporin of choice. Cephalothin was placed on a limited formulary status for ophthamology patients and patients with renal impairment. Efforts by the committee to promote physician compliance with its recommendations are discussed.
D001424:Bacterial Infections / Q000188:drug therapy*; D002437:Cefazolin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D004363:Drug Utilization; D005431:Florida; D006801:Humans; D010605:Pharmacy Administration; D010607:Pharmacy Service, Hospital; D010606:Pharmacy and Therapeutics Committee
D002511:Cephalosporins; D002437:Cefazolin